Related Experiment Video
Updated: Sep 24, 2025

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry
Published on: April 21, 2022
The Potential Role of m6A RNA Methylation in the Aging Process and Aging-Associated Diseases
Jin Sun1,2, Bokai Cheng1,2, Yongkang Su1,2
1Department of Geriatrics, The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
Abstract:
N6-methyladenosine (m6A) is the most common and conserved internal eukaryotic mRNA modification. m6A modification is a dynamic and reversible post-transcriptional regulatory modification, initiated by methylase and removed by RNA demethylase. m6A-binding proteins recognise the m6A modification to regulate gene expression. Recent studies have shown that altered m6A levels and abnormal regulator expression are crucial in the ageing process and the occurrence of age-related diseases. In this review, we summarise some key findings in the field of m6A modification in the ageing process and age-related diseases, including cell senescence, autophagy, inflammation, oxidative stress, DNA damage, tumours, neurodegenerative diseases, diabetes, and cardiovascular diseases (CVDs). We focused on the biological function and potential molecular mechanisms of m6A RNA methylation in ageing and age-related disease progression. We believe that m6A modification may provide a new target for anti-ageing therapies.
Insights
N6-methyladenosine (m6A) RNA methylation is vital in aging and age-related diseases. Targeting m6A pathways offers potential for novel anti-aging therapies.
Area of Science:
- Molecular Biology
- Epigenetics
- Gerontology
Background:
- N6-methyladenosine (m6A) is the most prevalent internal mRNA modification in eukaryotes.
- m6A is dynamically regulated by methylases and demethylases, influencing gene expression via m6A-binding proteins.
- Aberrant m6A levels and regulators are implicated in aging and age-related pathologies.
Purpose of the Study:
- To review the role of m6A modification in the aging process.
- To explore the molecular mechanisms of m6A in age-related disease progression.
- To highlight m6A as a potential therapeutic target for anti-aging strategies.
Main Methods:
- Literature review of recent studies on m6A in aging and age-related diseases.
- Focus on biological functions and molecular mechanisms.
- Synthesis of findings related to cell senescence, autophagy, inflammation, oxidative stress, DNA damage, tumors, neurodegenerative diseases, diabetes, and cardiovascular diseases.
Main Results:
- m6A modification plays a critical role in regulating key aging hallmarks.
- Altered m6A patterns are associated with the pathogenesis of diverse age-related conditions.
- Specific m6A regulators and their mechanisms are increasingly understood in the context of aging.
Conclusions:
- m6A RNA methylation is a significant factor in aging and the development of age-related diseases.
- Understanding m6A's role provides insights into disease mechanisms.
- m6A modification presents a promising target for future anti-aging interventions.
Related Concept Videos
RNA Stability
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Epigenetic Regulation
MicroRNAs
Nuclear Export of mRNA
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...

